|
| |
BioPortfolio's Approved Drugs DatabaseFentanylFentanyl CitrateDownload PDF containing detailed information.
Press Releases About Fentanyl:
|
 |
| Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32 |
29th October, 2009 |
Mylan Inc. |
-- On a GAAP basis, earnings per diluted share of $0.29 for the nine months
ended September 30, 2009.
Mylan's Chairman and CEO Robert J. Coury commented: "I am particularly
|
| Apotex to Distribute Important Transdermal System for Management of Chronic Pain in the U.S. Market |
20th October, 2009 |
Apotex Inc. |
WESTON, FL, Oct. 20 /PRNewswire/ - Apotex Corp announced today that it has signed an exclusive distribution agreement with Hisamitsu Pharmaceutical Company of Japan. Apotex will sell to the U.S.
|
| Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients |
13th October, 2009 |
Meda Pharmaceuticals Inc. |
-- Training prescribers, pharmacists, and patients about proper dosing and
administration.
Under the FOCUS Program, only prescribers, pharmacies, and patients registered with the
|
| Reportlinker Adds Liquid Chromatography Markets (LC, HPLC and UHPLC) Report |
24th September, 2009 |
Reportlinker |
-- Market Forecasts
-- Overview of the LC Market
-- Product Offerings by Company
-- Breakdown of LC Market by Region (US, Europe, Asia, ROW)
-- Detail of
|
| Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009 |
30th July, 2009 |
Mylan Inc. |
-- On a GAAP basis, the company reported diluted EPS of $0.19 and $0.42 for
the three and six months ended June 30, 2009, compared to a loss per
share of $0.05 and $1.52 in the
|
Companies working in the area of Fentanyl from Bioportfolio's Biocorporate database : | |
| Company Name | |
LAB International (LAB Pharma and LAB Research) is an integrated drug development company with subsidiaries focused on developing and manufacturing novel therapeutics for the multi-billion dollar...
www.labinc.fi/ View full profile
| |
YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company is advancing two late-stage products: nimotuzumab, a...
www.ymbiosciences.com View full profile
| |
This page has been viewed 42 times
Recent Search Terms used to find this page: archimedes pharma october 2009 | .
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Fentanyl across BioPortfolio, or for Fentanyl Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|
